PF-Atlas › Clinical Trials › NCT02976519

BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects

BI 443651 · Phase 1

Registry ID

NCT02976519

Phase

Phase 1

Status

Completed

Drug / intervention

BI 443651

Sponsor

Boehringer Ingelheim

Start

2017-02-15

Enrollment

Locations

About this trial

The objective of this study is to investigate the safety, tolerability, and pharmacokinetics of BI 443651 in male and female healthy volunteers and subjects with Cystic Fibrosis (CF).

View NCT02976519 on ClinicalTrials.gov →

Explore related

All BI 443651 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02976519 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.